• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MPRI ATTAIN ABILITY PLUS MRI SURESCAN; DRUG ELUTING PERMANENT LEFT VENTRICULAR (LV) P

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MPRI ATTAIN ABILITY PLUS MRI SURESCAN; DRUG ELUTING PERMANENT LEFT VENTRICULAR (LV) P Back to Search Results
Model Number 429688
Device Problem High impedance (1291)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/22/2017
Event Type  Injury  
Manufacturer Narrative
Continuation of d10: dtbb1d4 crt-d implanted:04-apr-2017 medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
It was reported that the right ventricular (rv) lead had a high voltage fracture, high/undefined rv coil impedance, rv coil impedance spike, low rv coil impedance, high/undefined superior vena cava (svc) coil impednace, svc coil impedance spike, low svc coil impedance.Additionally the left ventricular (lv) lead had an alert for high/undefined pacing impedance.The rv lead was reprogrammed and later replaced, and the lv lead is no longer in use.No patient complications have been reported as a result of this event.
 
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Manufacturer Narrative
Correction: b2; b5; imf (annex f) health impact codes.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
It was reported that the right ventricular (rv) lead had a high voltage fracture, high/undefined rv coil impedance, rv coil impedance spike, low rv coil impedance, high/undefined superior vena cava (svc) coil impedance, svc coil impedance spike, low svc coil impedance.Additionally the left ventricular (lv) lead had an alert for high/undefined pacing impedance.The rv lead was reprogrammed and later replaced, and the lv lead is no longer in use.No patient complications have been reported as a result of this event.It was additionally reported that the rv lead exhibited high undefined pacing impedance.The lv lead was capped and a left bundle branch lead was placed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATTAIN ABILITY PLUS MRI SURESCAN
Type of Device
DRUG ELUTING PERMANENT LEFT VENTRICULAR (LV) P
Manufacturer (Section D)
MPRI
road 149 km 56.3
villalba PR 00766
Manufacturer (Section G)
MPRI
road 149 km 56.3
villalba PR 00766
Manufacturer Contact
paula bixby
8200 coral sea st ne
mounds view, MN 55112
7635055378
MDR Report Key18949927
MDR Text Key338248517
Report Number2649622-2024-07774
Device Sequence Number1
Product Code OJX
UDI-Device Identifier00613994719133
UDI-Public00613994719133
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P080006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 05/21/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date02/16/2014
Device Model Number429688
Device Catalogue Number429688
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/28/2024
Initial Date FDA Received03/21/2024
Supplement Dates Manufacturer Received03/20/2024
05/21/2024
Supplement Dates FDA Received04/12/2024
05/21/2024
Date Device Manufactured04/03/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
6947M62 LEAD, 5076-52 LEAD
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age47 YR
Patient SexMale
-
-